Fondation MEDINA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Fondation MEDINA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013518
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fondation MEDINA (MEDINA) is a research organization that discovers biologically active molecules and drug candidates for unmet medical needs. The organization’s services include access to natural products libraries, drug discovery contract research with its high throughput screening platform, information on clinical research activities, and preclinical safety assessment of drug candidates. It participates in biomarker and drug discovery programs in the therapeutic areas of infectious diseases including tuberculosis and parasitic diseases; oncology; neurodegeneration and rare diseases. MEDINA collaborates with international research groups in academic and public international research institutions, and companies in pharmaceutical, biotechnology and agrochemical sectors. The organization offers contract research services for drug discovery and other biotechnology areas to academic research and industrial organizations. MEDINA is headquartered in Granada, Spain.

Fondation MEDINA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fondation MEDINA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fondation MEDINA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fondation MEDINA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fondation MEDINA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Fondation MEDINA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Fondation MEDINA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cyclenium Pharma Enters into Agreement with Fundacion Medina 10
Fundacion Medina Enters Into Research Agreement With Cubist Pharma 11
Ferrer Internacional Enters Into Research Agreement With Medina Foundation 12
Fondation MEDINA – Key Competitors 13
Fondation MEDINA – Key Employees 14
Fondation MEDINA – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Fondation MEDINA, Pharmaceuticals & Healthcare, Key Facts 2
Fondation MEDINA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fondation MEDINA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fondation MEDINA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fondation MEDINA, Deals By Therapy Area, 2011 to YTD 2017 8
Fondation MEDINA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cyclenium Pharma Enters into Agreement with Fundacion Medina 10
Fundacion Medina Enters Into Research Agreement With Cubist Pharma 11
Ferrer Internacional Enters Into Research Agreement With Medina Foundation 12
Fondation MEDINA, Key Competitors 13
Fondation MEDINA, Key Employees 14

★海外企業調査レポート[Fondation MEDINA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iBio Inc (IBIO):企業の財務・戦略的SWOT分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Salling Group AS:企業の戦略的SWOT分析
    Salling Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • CMC Biologics AS:製薬・医療:M&Aディール及び事業提携情報
    Summary CMC Biologics A/S (CMC Biologics), formerly CMC Biopharmaceuticals A/S, a subsidiary of Asahi Glass Co., Ltd., is a contract process development and manufacturer of biopharmaceuticals. The company's service portfolio encompasses process development, cGMP manufacturing, and quality and regula …
  • AutoZone, Inc.:企業の戦略・SWOT・財務情報
    AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report Summary AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Chiltern International Inc-製薬・医療分野:企業M&A・提携分析
    Summary Chiltern International Inc (Chiltern) is a contract research organization that provides clinical trial development services. It conducts clinical trials for medical devices, drugs, and diagnostics across all stages of development. The company offer wide range of services including clinical d …
  • S.A. Industrias Celulosa Aragonesa:企業の戦略・SWOT・財務情報
    S.A. Industrias Celulosa Aragonesa - Strategy, SWOT and Corporate Finance Report Summary S.A. Industrias Celulosa Aragonesa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Univision Communications Inc.:企業の戦略的SWOT分析
    Univision Communications Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • MGM Resorts International:企業のM&A・事業提携・投資動向
    MGM Resorts International - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MGM Resorts International Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Orbis Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orbis Biosciences Inc (Orbis) is a developer of pharmaceutical products that offers optimizes oral and injectable products. The company provides preclnical pipeline indications for pathologies including cancer, bronchiolitis, Eczema, atopic dermatitis, nephrotic syndrome, HIV, asthma, bunine …
  • Beaver Aerospace & Defense, Inc.:企業の戦略・SWOT・財務分析
    Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Metso Corp (METSO):石油・ガス:M&Aディール及び事業提携情報
    Summary Metso Corp (Metso) is an industrial machinery company that provides sustainable technology and services. It offers products such as mining and construction aggregates processing equipments, conveyers, separators, air classifiers, slurry pumps, industrial valves and controls, and waste shredd …
  • Woori Bank:企業の戦略・SWOT・財務情報
    Woori Bank - Strategy, SWOT and Corporate Finance Report Summary Woori Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • OSRAM Opto Semiconductors GmbH:企業の戦略的SWOT分析
    OSRAM Opto Semiconductors GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Horiba Ltd (6856):企業の財務・戦略的SWOT分析
    Summary Horiba Ltd (Horiba) is a manufacturer of precision instruments and systems. The company's product portfolio includes automotive mechatronics, emission measurement systems, test systems, in vitro diagnostic systems, gas and oxygen analyzers, monitoring devices, industrial conductivity meters, …
  • JPMorgan Chase & Co.:企業の戦略・SWOT・財務情報
    JPMorgan Chase & Co. - Strategy, SWOT and Corporate Finance Report Summary JPMorgan Chase & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Protagen AG-製薬・医療分野:企業M&A・提携分析
    Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa Ssc, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyeliti …
  • Meritage Midstream Services II LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Meritage Midstream Services II LLC (Meritage Midstream), a subsidiary of Howard Midstream Energy Partners LLC, is an oil and gas company that provides midstream services. The company offers natural gas gathering, compression and handling, NGL treating and processing; natural-gas liquids trea …
  • RadiSys Corp (RSYS):企業の財務・戦略的SWOT分析
    Summary RadiSys Corp (RadiSys) is a provider of communication services. The company offers products include mobility engine, mediaengine, dcengine and embedded Products. It offers contact support, serviceengine, conceptualization, software customization, network design and integration; testing and a …
  • Royal Mail plc (RMG):企業の財務・戦略的SWOT分析
    Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Intelligent InSites Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intelligent InSites Inc (Insites) is a provider of real-time operational intelligence for the health care industry. The company offers implementation, training, technical support, product maintenance and solution services. Its solutions include additional end-user training, additional integr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆